Doxter | Updates

By Niko

Doxter auf Expansionskurs!

Public
Public

doxter | Companisto

Wir sind auf Expansionskurs. In den vergangenen Wochen hat sich bei doxter einiges getan. Die doxter GmbH konnte in allen wichtigen Bereichen große Schritte erfolgreich absolvieren und einleiten.

Im Bereich Sales konnten wir bereits zwei neue Direktvertriebler für den Bereich München engagieren. Beide neuen Mitarbeiter waren ehemals bei Pfizer in der Pharma-Branche tätig - dies bereichert unser Sales-Team um hunderte neue Kontakte. Zudem werden diese Woche weitere Pharma-Direktvertriebler im Bereich Hamburg und damit Norddeutschland verpflichtet. Jeden Tag bekommt doxter bereits neue Kunden. Nun wird sich dies noch deutlich beschleunigen.

Außerdem konnten wir in der Produktentwicklung stark zulegen. Doxter hat nicht nur die doxter WebApp für den Kunden erfolgreich in das Produktportfolio mit aufgenommen, sondern ebenfalls eine White-Label-Lösung des Buchungssystems auf den Markt gebracht. Wir freuen uns sehr über diese Entwicklung, da hierdurch unsere Zielgruppe nahezu verdoppelt wurde.

Erste Implementierungen der White-Label-Lösung kann man hier einsehen:

http://www.zahnarzt-zimny.de/de/service/terminvereinbarung.html

Herzlichen Dank allen Companisten und denen, die es im Rahmen des Crowdinvestings noch werden wollen – Anteile an doxter sind noch vorhanden! Wir freuen uns auf die kommenden Wochen und Monate.

Euer doxter Team



Comments

Note

Investments in crowdfunding projects offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, these investments are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by splitting their investment amount between crowdfunding campaigns rather than investing all of it in one crowdfunding campaign. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the Companists are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the Companists – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, crowdfunding investments are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

100,000 €

Invested

421

Companists

6.25 %

Share Offered

Please note
The acquisition of this asset involves considerable risks and can lead to the complete loss of the assets used.

Follow us

Contact Us
Your contact for all questions about investing on Companisto:
Andreas Riedel
Investor Relations

Toll-free phone number for investors

0800 - 100 26 70 (DE)
0800 - 10 02 67 (AT)
0800 - 10 02 67 (CH)

Service hours Mo-Fr 9 a.m.- 7 p.m.

Companisto GmbH
Köpenicker Str. 154
10997 Berlin
TÜV geprüftes Online-Portal | Companisto
Source: Own research. Based on data from the German Private Equity and Venture Capital Association - BVK, among others.
Investor Support
Please register in order to see the complete profile of Doxter.
Already registered?    Log in